Abstract
Datamonitor' s Biotechnology: Global Industry Guide is an essential resource
for top-level data and analysis covering the biotechnology industry. It
includes detailed data on market size and segmentation, textual analysis of
the key trends and competitive landscape, and profiles of the leading
companies. This incisive report provides expert analysis on a global, regional
and country basis.
Scope of the Report
* Contains an executive summary and data on
value, volume and segmentation
* Provides textual analysis of the
industry' s prospects, competitive landscape and profiles of the leading
companies.
* Incorporates in-depth five forces competitive environment analysis and
scorecards
* Covers the Global, European and Asia-Pacific markets as
well as individual chapters on 5 major markets (France, Germany, Japan, the UK
and the US).
* Includes a five-year forecast of the industry
Highlights
The global biotechnology market grew by 10.6% in 2007 to reach a value of
$171,803 million.
In 2012, the market is forecast to have a value of $275,757 million, an
increase of 60.5% since 2007.
In value terms, the medical/healthcare segment generated 69.4% of the market
value.
In value terms, the Americas generated 53.7% of the market value
Why you should buy this report
* Spot future trends and
developments
* Inform your business decisions
* Add weight
to presentations and marketing materials
* Save time carrying out
entry-level research
Market Definition
The biotechnology market consists of the development, manufacturing and
marketing of products based on advanced biotechnology research. The market
value reflects revenues of companies within this industry from product sales,
licensing fees, royalties and research funding. Any currency conversions used
in the creation of this report have been calculated using constant 2007 annual
average exchange rates.
For the purpose of this report the Americas comprises Brazil, Canada, Mexico
and the US.
Europe comprises Belgium, the Czech Republic, Denmark, France, Germany,
Hungary, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden and the
UK.
Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea
and Taiwan.
The global figure comprises the Americas, Asia-Pacific and Europe.
Table of Contents
Table of Contents
CHAPTER 1 Introduction 23
1.1 What is this report
about? 23
1.2 Who is the target reader? 23
1.3 How to use this report
23
1.4 Definitions 24
CHAPTER 2 Global Biotechnology 25
2.1 Market
Overview 25
2.2 Market Value 26
2.3 Market Segmentation I 27
2.4
Market Segmentation II 28
2.5 Five Forces Analysis 29
2.6 Market
Forecasts 35
CHAPTER 3 Biotechnology in Asia-Pacific 36
3.1 Market
Overview 36
3.2 Market Value 37
3.3 Market Segmentation I 38
3.4
Market Segmentation II 39
3.5 Five Forces Analysis 40
3.6 Market
Forecasts 46
CHAPTER 4 Biotechnology in Europe 47
4.1 Market Overview
47
4.2 Market Value 48
4.3 Market Segmentation I 49
4.4 Market
Segmentation II 50
4.5 Five Forces Analysis 51
4.6 Market Forecasts
57
4.7 Demographics 58
CHAPTER 5 Biotechnology in Belgium 59
5.1
Market Overview 59
5.2 Market Value 60
5.3 Market Segmentation I
61
5.4 Market Segmentation II 62
5.5 Five Forces Analysis 63
5.6
Market Forecasts 69
5.7 Demographics 70
CHAPTER 6 Biotechnology in
Canada 72
6.1 Market Overview 72
6.2 Market Value 73
6.3 Market
Segmentation I 74
6.4 Market Segmentation II 75
6.5 Five Forces
Analysis 76
6.6 Market Forecasts 82
6.7 Demographics 83
CHAPTER 7
Biotechnology in China 85
7.1 Market Overview 85
7.2 Market Value
86
7.3 Market Segmentation I 87
7.4 Market Segmentation II 88
7.5
Five Forces Analysis 89
7.6 Market Forecasts 95
7.7 Demographics
96
CHAPTER 8 Biotechnology in France 98
8.1 Market Overview 98
8.2
Market Value 99
8.3 Market Segmentation I 100
8.4 Market Segmentation
II 101
8.5 Five Forces Analysis 102
8.6 Market Forecasts 108
8.7
Demographics 109
CHAPTER 9 Biotechnology in Germany 111
9.1 Market
Overview 111
9.2 Market Value 112
9.3 Market Segmentation I 113
9.4 Market Segmentation II 114
9.5 Five Forces Analysis 115
9.6 Market
Forecasts 121
9.7 Demographics 122
CHAPTER 10 Biotechnology in Italy
124
10.1 Market Overview 124
10.2 Market Value 125
10.3 Market
Segmentation I 126
10.4 Market Segmentation II 127
10.5 Five Forces
Analysis 128
10.6 Market Forecasts 134
10.7 Demographics 135
CHAPTER 11 Biotechnology in Japan 136
11.1 Market Overview 136
11.2
Market Value 136
11.3 Market Segmentation I 136
11.4 Market
Segmentation II 136
11.5 Five Forces Analysis 136
11.6 Market
Forecasts 136
11.7 Demographics 136
CHAPTER 12 Biotechnology in the
Netherlands 136
12.1 Market Overview 136
12.2 Market Value 136
12.3 Market Segmentation I 136
12.4 Market Segmentation II 136
12.5
Five Forces Analysis 136
12.6 Market Forecasts 136
12.7 Demographics
136
CHAPTER 13 Biotechnology in Spain 136
13.1 Market Overview 136
13.2 Market Value 136
13.3 Market Segmentation I 136
13.4 Market
Segmentation II 136
13.5 Five Forces Analysis 136
13.6 Market
Forecasts 136
13.7 Demographics 136
CHAPTER 14 Biotechnology in the
United Kingdom 136
14.1 Market Overview 136
14.2 Market Value 136
14.3 Market Segmentation I 136
14.4 Market Segmentation II 136
14.5
Five Forces Analysis 136
14.6 Market Forecasts 136
14.7 Demographics
136
CHAPTER 15 Biotechnology in the United States 136
15.1 Market
Overview 136
15.2 Market Value 136
15.3 Market Segmentation I 136
15.4 Market Segmentation II 136
15.5 Five Forces Analysis 136
15.6
Market Forecasts 136
15.7 Demographics 136
CHAPTER 16 COMPANY PROFILES
136
16.1 Leading Companies 136
CHAPTER 17 Appendix 136
17.1 Data
Research Methodology 136
List of Tables
Table 1: Global
Biotechnology Market Value: $ million, 2003-2007 26
Table 2: Global
Biotechnology Market Segmentation I: % Share, by Value, 2007 27
Table 3:
Global Biotechnology Market Segmentation II: % Share, by Value, 2007 28
Table 4: Global Biotechnology Market Value Forecast: $ million, 2007-2012
35
Table 5: Asia-Pacific Biotechnology Market Value: $ million, 2003-2007
37
Table 6: Asia-Pacific Biotechnology Market Segmentation I: % Share, by
Value, 2007 38
Table 7: Asia-Pacific Biotechnology Market Segmentation II:
% Share, by Value, 2007 39
Table 8: Asia-Pacific Biotechnology Market
Value Forecast: $ million, 2007-2012 46
Table 9: Europe Biotechnology
Market Value: $ million, 2003-2007 48
Table 10: Europe Biotechnology
Market Segmentation I: % Share, by Value, 2007 49
Table 11: Europe
Biotechnology Market Segmentation II: % Share, by Value, 2007 50
Table 12:
Europe Biotechnology Market Value Forecast: $ million, 2007-2012 57
Table
13: Europe Exchange Rate, 2003 58
Table 14: Belgium Biotechnology Market
Value: $ million, 2003-2007 60
Table 15: Belgium Biotechnology Market
Segmentation I: % Share, by Value, 2007 61
Table 16: Belgium Biotechnology
Market Segmentation II: % Share, by Value, 2007 62
Table 17: Belgium
Biotechnology Market Value Forecast: $ million, 2007-2012 69
Table 18:
Belgium Size of Population (million) , 2003-2007 70
Table 19: Belgium GDP
(Constant 2000 Prices, $ billion), 2003-2007 70
Table 20: Belgium
Inflation, 2003-2007 70
Table 21: Belgium Exchange Rate, 2003 71
Table
22: Canada Biotechnology Market Value: $ million, 2003-2007 73
Table 23:
Canada Biotechnology Market Segmentation I: % Share, by Value, 2007 74
Table 24: Canada Biotechnology Market Segmentation II: % Share, by Value, 2007
75
Table 25: Canada Biotechnology Market Value Forecast: $ million,
2007-2012 82
Table 26: Canada Size of Population (million) , 2003-2007
83
Table 27: Canada GDP (Constant 2000 Prices, $ billion), 2003-2007
83
Table 28: Canada Inflation, 2003-2007 83
Table 29: Canada Exchange
Rate, 2003 84
Table 30: China Biotechnology Market Value: $ million,
2003-2007 86
Table 31: China Biotechnology Market Segmentation I: % Share,
by Value, 2007 87
Table 32: China Biotechnology Market Segmentation II: %
Share, by Value, 2007 88
Table 33: China Biotechnology Market Value
Forecast: $ million, 2007-2012 95
Table 34: China Size of Population
(million) , 2003-2007 96
Table 35: China GDP (Constant 2000 Prices, $
billion), 2003-2007 96
Table 36: China Inflation, 2003-2007 96
Table
37: China Exchange Rate, 2003 97
Table 38: France Biotechnology Market
Value: $ million, 2003-2007 99
Table 39: France Biotechnology Market
Segmentation I: % Share, by Value, 2007 100
Table 40: France Biotechnology
Market Segmentation II: % Share, by Value, 2007 101
Table 41: France
Biotechnology Market Value Forecast: $ million, 2007-2012 108
Table 42:
France Size of Population (million) , 2003-2007 109
Table 43: France GDP
(Constant 2000 Prices, $ billion), 2003-2007 109
Table 44: France
Inflation, 2003-2007 109
Table 45: France Exchange Rate, 2003 110
Table 46: Germany Biotechnology Market Value: $ million, 2003-2007 112
Table 47: Germany Biotechnology Market Segmentation I: % Share, by Value, 2007
113
Table 48: Germany Biotechnology Market Segmentation II: % Share, by
Value, 2007 114
Table 49: Germany Biotechnology Market Value Forecast: $
million, 2007-2012 121
Table 50: Germany Size of Population (million) ,
2003-2007 122
Table 51: Germany GDP (Constant 2000 Prices, $ billion),
2003-2007 122
Table 52: Germany Inflation, 2003-2007 122
Table 53:
Germany Exchange Rate, 2003 123
Table 54: Italy Biotechnology Market
Value: $ million, 2003-2007 125
Table 55: Italy Biotechnology Market
Segmentation I: % Share, by Value, 2007 126
Table 56: Italy Biotechnology
Market Segmentation II: % Share, by Value, 2007 127
Table 57: Italy
Biotechnology Market Value Forecast: $ million, 2007-2012 134
Table 58:
Italy Size of Population (million) , 2003-2007 135
Table 59: Italy GDP
(Constant 2000 Prices, $ billion), 2003-2007 135
Table 60: Italy
Inflation, 2003-2007 135
Table 61: Italy Exchange Rate, 2003 136
Table
62: Japan Biotechnology Market Value: $ million, 2003-2007 136
Table 63:
Japan Biotechnology Market Segmentation I: % Share, by Value, 2007 136
Table 64: Japan Biotechnology Market Segmentation II: % Share, by Value, 2007
136
Table 65: Japan Biotechnology Market Value Forecast: $ million,
2007-2012 136
Table 66: Japan Size of Population (million) , 2003-2007
136
Table 67: Japan GDP (Constant 2000 Prices, $ billion), 2003-2007
136
Table 68: Japan Exchange Rate, 2003 136
Table 69: Netherlands
Biotechnology Market Value: $ million, 2003-2007 136
Table 70: Netherlands
Biotechnology Market Segmentation I: % Share, by Value, 2007 136
Table
71: Netherlands Biotechnology Market Segmentation II: % Share, by Value, 2007
136
Table 72: Netherlands Biotechnology Market Value Forecast: $ million,
2007-2012 136
Table 73: Netherlands Size of Population (million) ,
2003-2007 136
Table 74: Netherlands GDP (Constant 2000 Prices, $ billion),
2003-2007 136
Table 75: Netherlands Inflation, 2003-2007 136
Table 76:
Netherlands Exchange Rate, 2003 136
Table 77: Spain Biotechnology Market
Value: $ million, 2003-2007 136
Table 78: Spain Biotechnology Market
Segmentation I: % Share, by Value, 2007 136
Table 79: Spain Biotechnology
Market Segmentation II: % Share, by Value, 2007 136
Table 80: Spain
Biotechnology Market Value Forecast: $ million, 2007-2012 136
Table 81:
Spain Size of Population (million) , 2003-2007 136
Table 82: Spain GDP
(Constant 2000 Prices, $ billion), 2003-2007 136
Table 83: Spain
Inflation, 2003-2007 136
Table 84: Spain Exchange Rate, 2003 136
Table
85: United Kingdom Biotechnology Market Value: $ million, 2003-2007 136
Table 86: United Kingdom Biotechnology Market Segmentation I: % Share, by
Value, 2007 136
Table 87: United Kingdom Biotechnology Market
Segmentation II: % Share, by Value, 2007 136
Table 88: United Kingdom
Biotechnology Market Value Forecast: $ million, 2007-2012 136
Table 89:
United Kingdom Size of Population (million) , 2003-2007 136
Table 90:
United Kingdom GDP (Constant 2000 Prices, $ billion), 2003-2007 136
Table
91: United Kingdom Inflation, 2003-2007 136
Table 92: United Kingdom
Exchange Rate, 2003 136
Table 93: United States Biotechnology Market
Value: $ million, 2003-2007 136
Table 94: United States Biotechnology
Market Segmentation I: % Share, by Volume, 2007 136
Table 95: United
States Biotechnology Market Segmentation II: % Share, by Value, 2007 136
Table 96: United States Biotechnology Market Value Forecast: $ million,
2007-2012 136
Table 97: United States Size of Population (million) ,
2003-2007 136
Table 98: United States GDP (Constant 2000 Prices, $
billion), 2003-2007 136
Table 99: United States Inflation, 2003-2007
136
Table 100: Key Facts: Amgen Inc. 136
Table 101: Key Financials:
Amgen Inc. 136
Table 102: Key Facts: Genentech, Inc. 136
Table 103:
Key Financials: Genentech, Inc. 136
Table 104: Key Facts: Biogen Idec,
Inc. 136
Table 105: Key Financials: Biogen Idec, Inc. 136
List of Figures
Figure 1: Global Biotechnology Market Value: $ million,
2003-2007 26
Figure 2: Global Biotechnology Market Segmentation I: %
Share, by Value, 2007 27
Figure 3: Global Biotechnology Market
Segmentation II: % Share, by Value, 2007 28
Figure 4: Forces Driving
Competition in the Global Biotechnology Market, 2007 29
Figure 5: Drivers
of Buyer Power in the Global Biotechnology Market, 2007 30
Figure 6:
Drivers of Supplier Power in the Global Biotechnology Market, 2007 31
Figure 7: Factors Influencing the Likelihood of New Entrants in the Global
Biotechnology Market, 2007 32
Figure 8: Factors Influencing the Threat of
Substitutes in the MARKET NAME in COUNTRY, 2007 33
Figure 9: Drivers of
Degree of Rivalry in the Global Biotechnology Market, 2007 34
Figure 10:
Global Biotechnology Market Value Forecast: $ million, 2007-2012 35
Figure
11: Asia-Pacific Biotechnology Market Value: $ million, 2003-2007 37
Figure 12: Asia-Pacific Biotechnology Market Segmentation I: % Share, by
Value, 2007 38
Figure 13: Asia-Pacific Biotechnology Market Segmentation
II: % Share, by Value, 2007 39
Figure 14: Forces Driving Competition in
the Biotechnology Market in Asia-Pacific, 2007 40
Figure 15: Drivers of
Buyer Power in the Biotechnology Market in Asia-Pacific, 2007 41
Figure
16: Drivers of Supplier Power in the Biotechnology Market in Asia-Pacific,
2007 42
Figure 17: Factors Influencing the Likelihood of New Entrants in
the Biotechnology Market in Asia-Pacific, 2007 43
Figure 18: Factors
Influencing the Threat of Substitutes in the Biotechnology Market in
Asia-Pacific, 2007 44
Figure 19: Drivers of Degree of Rivalry in the
Biotechnology Market in Asia-Pacific, 2007 45
Figure 20: Asia-Pacific
Biotechnology Market Value Forecast: $ million, 2007-2012 46
Figure 21:
Europe Biotechnology Market Value: $ million, 2003-2007 48
Figure 22:
Europe Biotechnology Market Segmentation I: % Share, by Value, 2007 49
Figure 23: Europe Biotechnology Market Segmentation II: % Share, by Value,
2007 50
Figure 24: Forces Driving Competition in the Biotechnology market
in Europe, 2007 51
Figure 25: Drivers of Buyer Power in the Biotechnology
market in Europe, 2007 52
Figure 26: Drivers of Supplier Power in the
Biotechnology market in Europe, 2007 53
Figure 27: Factors Influencing the
Likelihood of New Entrants in the Biotechnology market in Europe, 2007 54
Figure 28: Factors Influencing the Threat of Substitutes in the Biotechnology
market in Europe, 2007 55
Figure 29: Drivers of Degree of Rivalry in the
Biotechnology market in Europe, 2007 56
Figure 30: Europe Biotechnology
Market Value Forecast: $ million, 2007-2012 57
Figure 31: Belgium
Biotechnology Market Value: $ million, 2003-2007 60
Figure 32: Belgium
Biotechnology Market Segmentation I: % Share, by Value, 2007 61
Figure 33:
Belgium Biotechnology Market Segmentation II: % Share, by Value, 2007 62
Figure 34: Forces Driving Competition in the Biotechnology Market in Belgium,
2007 63
Figure 35: Drivers of Buyer Power in the Biotechnology Market in
Belgium, 2007 64
Figure 36: Drivers of Supplier Power in the Biotechnology
Market in Belgium, 2007 65
Figure 37: Factors Influencing the Likelihood
of New Entrants in the Biotechnology Market in Belgium, 2007 66
Figure 38:
Factors Influencing the Threat of Substitutes in the Biotechnology Market in
Belgium, 2007 67
Figure 39: Drivers of Degree of Rivalry in the
Biotechnology Market in Belgium, 2007 68
Figure 40: Belgium Biotechnology
Market Value Forecast: $ million, 2007-2012 69
Figure 41: Canada
Biotechnology Market Value: $ million, 2003-2007 73
Figure 42: Canada
Biotechnology Market Segmentation I: % Share, by Value, 2007 74
Figure 43:
Canada Biotechnology Market Segmentation II: % Share, by Value, 2007 75
Figure 44: Forces Driving Competition in the Biotechnology Market in Canada,
2007 76
Figure 45: Drivers of Buyer Power in the Biotechnology Market in
Canada, 2007 77
Figure 46: Drivers of Supplier Power in the Biotechnology
Market in Canada, 2007 78
Figure 47: Factors Influencing the Likelihood of
New Entrants in the Biotechnology Market in Canada, 2007 79
Figure 48:
Factors Influencing the Threat of Substitutes in the Biotechnology Market in
Canada, 2007 80
Figure 49: Drivers of Degree of Rivalry in the
Biotechnology Market in Canada, 2007 81
Figure 50: Canada Biotechnology
Market Value Forecast: $ million, 2007-2012 82
Figure 51: China
Biotechnology Market Value: $ million, 2003-2007 86
Figure 52: China
Biotechnology Market Segmentation I: % Share, by Value, 2007 87
Figure 53:
China Biotechnology Market Segmentation II: % Share, by Value, 2007 88
Figure 54: Forces Driving Competition in the Biotechnology Market in China,
2007 89
Figure 55: Drivers of Buyer Power in the Biotechnology Market in
China, 2007 90
Figure 56: Drivers of Supplier Power in the Biotechnology
Market in China, 2007 91
Figure 57: Factors Influencing the Likelihood of
New Entrants in the Biotechnology Market in China, 2007 92
Figure 58:
Factors Influencing the Threat of Substitutes in the Biotechnology Market in
China, 2007 93
Figure 59: Drivers of Degree of Rivalry in the
Biotechnology Market in China, 2007 94
Figure 60: China Biotechnology
Market Value Forecast: $ million, 2007-2012 95
Figure 61: France
Biotechnology Market Value: $ million, 2003-2007 99
Figure 62: France
Biotechnology Market Segmentation I: % Share, by Value, 2007 100
Figure
63: France Biotechnology Market Segmentation II: % Share, by Value, 2007
101
Figure 64: Forces Driving Competition in the Biotechnology Market in
France, 2007 102
Figure 65: Drivers of Buyer Power in the Biotechnology
Market in France, 2007 103
Figure 66: Drivers of Supplier Power in the
Biotechnology Market in France, 2007 104
Figure 67: Factors Influencing
the Likelihood of New Entrants in the Biotechnology Market in France, 2007
105
Figure 68: Factors Influencing the Threat of Substitutes in the
Biotechnology Market in France, 2007 106
Figure 69: Drivers of Degree of
Rivalry in the Biotechnology Market in France, 2007 107
Figure 70: France
Biotechnology Market Value Forecast: $ million, 2007-2012 108
Figure 71:
Germany Biotechnology Market Value: $ million, 2003-2007 112
Figure 72:
Germany Biotechnology Market Segmentation I: % Share, by Value, 2007 113
Figure 73: Germany Biotechnology Market Segmentation II: % Share, by Value,
2007 114
Figure 74: Forces Driving Competition in the Biotechnology Market
in Germany, 2007 115
Figure 75: Drivers of Buyer Power in the
Biotechnology Market in Germany, 2007 116
Figure 76: Drivers of Supplier
Power in the Biotechnology Market in Germany, 2007 117
Figure 77: Factors
Influencing the Likelihood of New Entrants in the Biotechnology Market in
Germany, 2007 118
Figure 78: Factors Influencing the Threat of Substitutes
in the Biotechnology Market in Germany, 2007 119
Figure 79: Drivers of
Degree of Rivalry in the Biotechnology Market in Germany, 2007 120
Figure
80: Germany Biotechnology Market Value Forecast: $ million, 2007-2012 121
Figure 81: Italy Biotechnology Market Value: $ million, 2003-2007 125
Figure 82: Italy Biotechnology Market Segmentation I: % Share, by Value, 2007
126
Figure 83: Italy Biotechnology Market Segmentation II: % Share, by
Value, 2007 127
Figure 84: Forces Driving Competition in the Biotechnology
Market in Italy, 2007 128
Figure 85: Drivers of Buyer Power in the
Biotechnology Market in Italy, 2007 129
Figure 86: Drivers of Supplier
Power in the Biotechnology Market in Italy, 2007 130
Figure 87: Factors
Influencing the Likelihood of New Entrants in the Biotechnology Market in
Italy, 2007 131
Figure 88: Factors Influencing the Threat of Substitutes
in the Biotechnology Market in Italy, 2007 132
Figure 89: Drivers of
Degree of Rivalry in the Biotechnology Market in Italy, 2007 133
Figure
90: Italy Biotechnology Market Value Forecast: $ million, 2007-2012 134
Figure 91: Japan Biotechnology Market Value: $ million, 2003-2007 136
Figure 92: Japan Biotechnology Market Segmentation I: % Share, by Value, 2007
136
Figure 93: Japan Biotechnology Market Segmentation II: % Share, by
Value, 2007 136
Figure 94: Forces Driving Competition in the Biotechnology
Market in Japan, 2007 136
Figure 95: Drivers of Buyer Power in the
Biotechnology Market in Japan, 2007 136
Figure 96: Drivers of Supplier
Power in the Biotechnology Market in Japan, 2007 136
Figure 97: Factors
Influencing the Likelihood of New Entrants in the Biotechnology Market in
Japan, 2007 136
Figure 98: Factors Influencing the Threat of Substitutes
in the Biotechnology Market in Japan, 2007 136
Figure 99: Drivers of
Degree of Rivalry in the MARKET NAME in COUNTRY, 2007 136
Figure 100:
Japan Biotechnology Market Value Forecast: $ million, 2007-2012 136
Figure
101: Netherlands Biotechnology Market Value: $ million, 2003-2007 136
Figure 102: Netherlands Biotechnology Market Segmentation I: % Share, by
Value, 2007 136
Figure 103: Netherlands Biotechnology Market
Segmentation II: % Share, by Value, 2007 136
Figure 104: Forces Driving
Competition in the Biotechnology Market in the Netherlands, 2007 136
Figure 105: Drivers of Buyer Power in the Biotechnology Market in the
Netherlands, 2007 136
Figure 106: Drivers of Supplier Power in the
Biotechnology Market in the Netherlands, 2007 136
Figure 107: Factors
Influencing the Likelihood of New Entrants in the Biotechnology Market in the
Netherlands, 2007 136
Figure 108: Factors Influencing the Threat of
Substitutes in the Biotechnology Market in the Netherlands, 2007 136
Figure 109: Drivers of Degree of Rivalry in the Biotechnology Market in the
Netherlands, 2007 136
Figure 110: Netherlands Biotechnology Market Value
Forecast: $ million, 2007-2012 136
Figure 111: Spain Biotechnology Market
Value: $ million, 2003-2007 136
Figure 112: Spain Biotechnology Market
Segmentation I: % Share, by Value, 2007 136
Figure 113: Spain
Biotechnology Market Segmentation II: % Share, by Value, 2007 136
Figure
114: Forces Driving Competition in the Biotechnology Market in Spain, 2007
136
Figure 115: Drivers of Buyer Power in the Biotechnology Market in
Spain, 2007 136
Figure 116: Drivers of Supplier Power in the Biotechnology
Market in Spain, 2007 136
Figure 117: Factors Influencing the Likelihood
of New Entrants in the Biotechnology Market in Spain, 2007 136
Figure 118:
Factors Influencing the Threat of Substitutes in the Biotechnology Market in
Spain, 2007 136
Figure 119: Drivers of Degree of Rivalry in the
Biotechnology Market in Spain, 2007 136
Figure 120: Spain Biotechnology
Market Value Forecast: $ million, 2007-2012 136
Figure 121: United Kingdom
Biotechnology Market Value: $ million, 2003-2007 136
Figure 122: United
Kingdom Biotechnology Market Segmentation I: % Share, by Value, 2007 136
Figure 123: United Kingdom Biotechnology Market Segmentation II: % Share, by
Value, 2007 136
Figure 124: Forces Driving Competition in the
Biotechnology Market in the UK, 2007 136
Figure 125: Drivers of Buyer
Power in the Biotechnology Market in the UK, 2007 136
Figure 126: Drivers
of Supplier Power in the Biotechnology Market in the UK, 2007 136
Figure
127: Factors Influencing the Likelihood of New Entrants in the Biotechnology
Market in the UK, 2007 136
Figure 128: Factors Influencing the Threat of
Substitutes in the Biotechnology Market in the UK, 2007 136
Figure 129:
Drivers of Degree of Rivalry in the Biotechnology Market in the UK, 2007
136
Figure 130: United Kingdom Biotechnology Market Value Forecast: $
million, 2007-2012 136
Figure 131: United States Biotechnology Market
Value: $ million, 2003-2007 136
Figure 132: United States Biotechnology
Market Segmentation I: % Share, by Volume, 2007 136
Figure 133: United
States Biotechnology Market Segmentation II: % Share, by Value, 2007 136
Figure 134: Forces Driving Competition in the Biotechnology Market in the US,
2007 136
Figure 135: Drivers of Buyer Power in the Biotechnology Market in
the US, 2007 136
Figure 136: Drivers of Supplier Power in the
Biotechnology Market in the US, 2007 136
Figure 137: Factors Influencing
the Likelihood of New Entrants in the Biotechnology Market in the US, 2007
136
Figure 138: Factors Influencing the Threat of Substitutes in the
Biotechnology Market in the US, 2007 136
Figure 139: Drivers of Degree of
Rivalry in the Biotechnology Market in the US, 2007 136
Figure 140: United
States Biotechnology Market Value Forecast: $ million, 2007-2012 136
Figure 141: Revenues & Profitability: Amgen Inc. 136
Figure 142: Revenues
& Profitability: Genentech, Inc. 136
Figure 143: Revenues & Profitability:
Biogen Idec, Inc. 136
|
相關報告
|
